HealthTree Foundation for Diffuse Large B Cell Lymphoma, Bispecific Antibodies (BsAb) Treatments and Medications

Bispecific Antibodies (BsAb)

Bispecific antibodies act as a go-between, recognizing and attaching to cancer cells and joining them to the immune system’s T cells. That cancer cell-to-T cell attachment results in the T cells attacking cancer cells.

Talquetamab (Talvey®) VIEW TREATMENT Elranatamab (Elrexfrio™) VIEW TREATMENT Teclistamab (Tecvayli®) VIEW TREATMENT

All HealthTree resources available anywhere, anytime

Download our App

Download our App

Charity Navigator

HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.

Tax ID 45-5354811

Education

Community

Cure Hub

Get Involved

About us

Need Help?

Legal Info

Follow Us

Get the Latest Large B Cell Lymphoma Updates, Delivered to You.